articles details

Research
June 15, 2025

Aleeto® Lyophilized Powder for Injection (ALEETO®)

1)Dosage Form Characteristics:
This lyophilized powder is intended for reconstitution and parenteral administration, providing rapid, stable systemic drug exposure. It is ideally suited for acute or critically ill patients.
2)Indications:
• Amyotrophic lateral sclerosis (ALS)
• Stroke (acute, subacute, and post-stroke rehabilitation phases)
• Neurodegenerative diseases such as Alzheimer’s disease (AD)
3)Key Advantages:
• Potent Systemic Effect: Intravenous or intramuscular injection allows for fast onset of action.
• Precise Dose Control: Facilitates accurate titration and adjustment of therapeutic dosing.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Popular Post

Caring for the Elderly, Safeguarding Memory – Alzheimer’s Disease Science-Popularization Open Day Successfully Held — DarwinCell Biotech Alzheimer’s Disease Public Science Open Day
DarwinCell Showcases novel MSC-based drug ALT001 at the 150th American Neurological Association Annual Meeting
Darwin Biotech Chairwoman Yu Wang Named “Beijing March 8th Red-Banner Holder”: Illuminating New Hope for Life Through Science

Categories

  • Research Insights (02)
  • Laboratory Best Practices (04)
  • Innovation & Technology (01)
  • Industry Trends (03)
  • Sustainability in Science (05)
  • Events & Workshops (02)
  • Educational Resources (04)